306 related articles for article (PubMed ID: 11412299)
21. New insight into immunological mechanisms of venom immunotherapy.
Ewan PW
Curr Opin Allergy Clin Immunol; 2001 Aug; 1(4):367-74. PubMed ID: 11964715
[TBL] [Abstract][Full Text] [Related]
22. Immune regulation by CD4+CD25+ T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls.
Thunberg S; Akdis M; Akdis CA; Grönneberg R; Malmström V; Trollmo C; van Hage M; Gafvelin G
Clin Exp Allergy; 2007 Aug; 37(8):1127-36. PubMed ID: 17651141
[TBL] [Abstract][Full Text] [Related]
23. Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells.
Park W; Weyand CM; Schmidt D; Goronzy JJ
Eur J Immunol; 1997 May; 27(5):1082-90. PubMed ID: 9174596
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-10-treated dendritic cells do not inhibit Th2 immune responses in ovalbumin/alum-sensitized mice.
Bellinghausen I; Sudowe S; König B; Reske-Kunz AB; Knop J; Saloga J
Int Arch Allergy Immunol; 2006; 141(1):61-9. PubMed ID: 16804328
[TBL] [Abstract][Full Text] [Related]
25. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
[TBL] [Abstract][Full Text] [Related]
26. Regulation by cytokines (IL-12, IL-15, IL-4 and IL-10) of the Vgamma9Vdelta2 T cell response to mycobacterial phosphoantigens in responder and anergic HIV-infected persons.
Boullier S; Poquet Y; Debord T; Fournie JJ; Gougeon ML
Eur J Immunol; 1999 Jan; 29(1):90-9. PubMed ID: 9933090
[TBL] [Abstract][Full Text] [Related]
27. Antigen-independent Th2 cell differentiation by stimulation of CD28: regulation via IL-4 gene expression and mitogen-activated protein kinase activation.
Skapenko A; Lipsky PE; Kraetsch HG; Kalden JR; Schulze-Koops H
J Immunol; 2001 Apr; 166(7):4283-92. PubMed ID: 11254680
[TBL] [Abstract][Full Text] [Related]
28. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases.
Marciani DJ
Autoimmunity; 2017 Nov; 50(7):393-402. PubMed ID: 28906131
[TBL] [Abstract][Full Text] [Related]
29. p38 alpha mitogen-activated protein kinase is activated by CD28-mediated signaling and is required for IL-4 production by human CD4+CD45RO+ T cells and Th2 effector cells.
Schafer PH; Wadsworth SA; Wang L; Siekierka JJ
J Immunol; 1999 Jun; 162(12):7110-9. PubMed ID: 10358155
[TBL] [Abstract][Full Text] [Related]
30. Importance of CD80/CD86-CD28 interactions in the recognition of target cells by CD8+CD122+ regulatory T cells.
Shi Z; Rifa'i M; Lee YH; Shiku H; Isobe K; Suzuki H
Immunology; 2008 May; 124(1):121-8. PubMed ID: 18205792
[TBL] [Abstract][Full Text] [Related]
31. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
32. Massive production of Th2 cytokines by human CD4+ effector T cells transiently expressing the natural killer cell marker CD57/HNK1.
Brinkmann V; Kristofic C
Immunology; 1997 Aug; 91(4):541-7. PubMed ID: 9378492
[TBL] [Abstract][Full Text] [Related]
33. Ligation of CD28 on resting T cells by its ligand B7 results in the induction of both Th1- and Th2-type cytokines.
Walter H; Schepensn S; Van Wauwe J; de Boer M
Eur Cytokine Netw; 1994; 5(1):13-21. PubMed ID: 7519453
[TBL] [Abstract][Full Text] [Related]
34. Impaired CD28-mediated co-stimulation in anergic T cells.
Suzuki G; Nomura M; Uzawa A; Akashi M; Nakata Y
Int Immunol; 1995 Jan; 7(1):37-43. PubMed ID: 7718514
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of allergen-specific antibodies in allergy and specific immunotherapy.
Blaser K; Akdis CA; Faith A
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1999; (93):243-51; discussion 252. PubMed ID: 11487881
[TBL] [Abstract][Full Text] [Related]
36. IL-10-producing T regulatory type 1 cells and oral tolerance.
Battaglia M; Gianfrani C; Gregori S; Roncarolo MG
Ann N Y Acad Sci; 2004 Dec; 1029():142-53. PubMed ID: 15681753
[TBL] [Abstract][Full Text] [Related]
37. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure.
Meiler F; Zumkehr J; Klunker S; Rückert B; Akdis CA; Akdis M
J Exp Med; 2008 Nov; 205(12):2887-98. PubMed ID: 19001136
[TBL] [Abstract][Full Text] [Related]
38. Engagement of distinct epitopes on CD43 induces different co-stimulatory pathways in human T cells.
Modak M; Majdic O; Cejka P; Jutz S; Puck A; Gerwien JG; Steinberger P; Zlabinger GJ; Strobl H; Stöckl J
Immunology; 2016 Nov; 149(3):280-296. PubMed ID: 27392084
[TBL] [Abstract][Full Text] [Related]
39. Induction of interleukin 12 responsiveness is impaired in anergic T lymphocytes.
Quill H; Bhandoola A; Trinchieri G; Haluskey J; Peritt D
J Exp Med; 1994 Mar; 179(3):1065-70. PubMed ID: 7906705
[TBL] [Abstract][Full Text] [Related]
40. Allergen immunotherapy and tolerance.
Matsuoka T; Shamji MH; Durham SR
Allergol Int; 2013 Dec; 62(4):403-13. PubMed ID: 24280670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
